JOSEPH SALZILLO: Open Payments
NPI 1881030153 · MILFORD, CT. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$940 in 23 payments from 6 companies in 2025. Trend: 2023 $176 · 2024 $350 · 2025 $940
Food & beverage: $940
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 3 | $352 |
| GlaxoSmithKline, LLC. | 10 | $309 |
| Optinose US, Inc. | 5 | $122 |
| Regeneron Healthcare Solutions, Inc. | 2 | $61 |
| Phathom Pharmaceuticals, Inc. | 2 | $50 |
| Stryker Corporation | 1 | $46 |
Products named: NUCALA, BREZTRI, Xhance, AIRSUPRA, DUPIXENT, VOQUEZNA, XPRESS LOPROFILE.
Industry payments across CT — which companies pay providers there.
